Arkolith/Insider Trading/BTX/Form 4

Gurrola Sandra M

Vice President of FinanceBrooklyn ImmunoTherapeutics, Inc. (BTX) · full profile →Form 4 · filed Jun 23, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 21, 2022Option exercise(M)9K——17K
Jun 21, 2022Tax withholding(F)4K$0.48$2K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 21, 2022Option exercise(M)9K—$026K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-023928) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML